By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272




Company News
Ironwood Pharmaceuticals (IRWD) Earns $15 Million Milestone From Astellas Pharma Inc. (ALPMY) 11/20/2014 7:13:50 AM
Changing Tomorrow Day 2014 Marks Astellas Pharma Inc. (ALPMY)' Fifth Annual Global Service Initiative 11/4/2014 8:26:49 AM
Dana-Farber Cancer Institute And Astellas Pharma Inc. (ALPMY) Announce Research Collaboration 11/4/2014 7:21:32 AM
Astellas Pharma Inc. (ALPMY), Proteostasis Therapeutics, Inc. Forge $1.2 Billion Genetic Disease Drug Pact 11/4/2014 5:51:14 AM
FDA Grants Orphan Drug Designation To Astellas Pharma Inc. (ALPMY) For Isavuconazole For The Treatment Of Invasive Candidiasis 11/3/2014 8:43:33 AM
QIAGEN N.V. (QGEN) Announces Broad Agreement With Astellas Pharma Inc. (ALPMY) To Develop Companion Diagnostics 10/29/2014 7:32:23 AM
Astellas Pharma Inc. (ALPMY)'s XTANDI™ (Enzalutamide) Capsules Receive Positive CHMP Opinion For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve 10/24/2014 10:58:35 AM
Astellas Pharma Inc. (ALPMY), CoMentis, Inc. Terminate Alzheimer's Agreement 10/17/2014 6:24:11 AM
Astellas Pharma Inc. (ALPMY) Announces Research Collaboration With Harvard Medical School Investigator For Treatment Of Retinal Degeneration 10/14/2014 8:14:55 AM
Astellas Pharma Inc. (ALPMY) Presents New Findings For Isavuconazole In Mucormycosis At IDWeek 10/8/2014 8:33:13 AM